Protective effect of caffeine on streptozotocin-induced beta-cell damage in rats

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 9, 2008, Pages 1161-1165

  Kagami, Keisuke ^a   Morita, Hajime ^a   Onda, Kenji ^a   Hirano, Toshihiko ^a   Oka, Kitaro ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; INSULIN; SODIUM CHLORIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; RAT;

ANIMALS; BLOOD GLUCOSE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE TOLERANCE TEST; INSULIN-SECRETING CELLS; MALE; RATS; RATS, WISTAR; STREPTOZOCIN;

EID: 49749112358     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.9.0007     Document Type: Article

References (22)

1. Cnop, M., Welsh, N., Jonas, J. C., Jörns, A., Lenzen, S., Eizirik, D. L. (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54: S97-S107
2. Donath, M. Y., Størling, J., Maedler, K., Mandrup-Poulsen, T. (2003) Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol. Med. 81: 455-470
3. Donath, M. Y., Ehses, J. A., Maedler, K., Schumann, D. M., Ellingsgaard, H., Eppler, E., Reinecke, M. (2005) Mechanisms of beta-cell death in type 2 diabetes. Diabetes 54: S108-S113
4. Eldor, R., Yeffet, A., Baum, K., Doviner, V., Amar, D., Ben-Neriah, Y., Christofori, G., Peled, A., Carel, J. C, Boitard, C., Klein, T., Serup, P., Eizirik, D. L., Melloul, D. (2006) Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc. Natl Acad. Sci. USA 103: 5072-5077
5. Geraets, L., Moonen, H. J., Wouters, E. F., Bast, A., Hageman, G. J. (2006) Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations. Biochem. Pharmacol. 72: 902-910
6. Greenberg, J. A., Boozer, C. N., Geliebter, A. (2006) Coffee, diabetes, and weight control. Am. J. Clin. Nutr. 84: 682-693
7. Hassa, P. O., Hottiger, M. O. (2002) The functional role of poly (ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol. Life Sci. 59: 1534-1553
8. Ho, E., Quan, N., Tsai, Y. H., Lai, W., Bray, T. M. (2001) Dietary zinc supplementation inhibits NFkappaB activation and protects against chemically induced diabetes in CDI mice. Exp. Biol. Med. (Maywood) 226: 103-111
9. Horrigan, L. A., Kelly, J. P., Connor, T. J. (2006) Immunomodulatory effects of caffeine: friend or foe? Pharmacol. Ther. 111: 877-892
10. Iso, H., Date, C., Wakai, K., Fukui, M., Tamakoshi, A.; JACC Study Group. (2006) The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann. Intern. Med. 144: 554-562
11. Keijzers, G. B., De Galan, B. E., Tack, C. J., Smits, P. (2002) Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25: 364-369
12. Lo, H. C., Tu, S. T., Lin, K. C., Lin, S. C. (2004) The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin. Life Sci. 74: 2897-2908
13. Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., Donath, M. Y. (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J. Clin. Invest. 110: 851-860
14. Masiello, P., Broca, C., Gross, R., Roye, M., Manteghetti, M., Hillaire-Buys, D., Novelli, M., Ribes, G. (1998) Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 47: 224-229
15. Minamisawa, M., Yoshida, S., Takai, N. (2004) Determination of biologically active substances in roasted coffees using a diode-array HPLC system. Anal. Sci. 20: 325-328
16. Oka, K. (2007) Pharmacological bases of coffee nutrients for diabetes prevention. Yakugaku Zasshi 127: 1825-1836
17. Park, S., Jang, J. S., Hong, S. M. (2007) Long-term consumption of caffeine improves glucose homeostasis by enhancing insulino-tropic action through islet insulin/insulin-like growth factor 1 signaling in diabetic rats. Metabolism 56: 599-607
18. Robertson, R. P., Harmon, J., Tran, P. O., Poitout, V. (2004) Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53: S119-S124
19. Spriet, L. L., MacLean, D. A., Dyck, D. J., Hultman, E., Cederblad, G., Graham, T. E. (1992) Caffeine ingestion and muscle metabolism during prolonged exercise in humans. Am. J. Physiol. 262: E891-E898
20. Szkudelski, T. (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50: 537-546
21. van Dam, R. M. (2006) Coffee and type 2 diabetes: from beans to beta-cells. Nutr. Metab. Cardiovasc. Dis. 16: 69-77
22. van Dam, R. M., Hu, F. B. (2005) Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294: 97-104